-
1
-
-
41949086822
-
What causes hidradenitis suppurativa?
-
Kurzen H, Kurokawa I, Jemec GB, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17(5):455-472
-
(2008)
Exp Dermatol.
, vol.17
, Issue.5
, pp. 455-472
-
-
Kurzen, H.1
Kurokawa, I.2
Jemec, G.B.3
-
2
-
-
84856007016
-
Clinical practice: Hidradenitis suppurativa
-
Jemec GBE. Clinical practice: Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158-164
-
(2012)
N Engl J Med.
, vol.366
, Issue.2
, pp. 158-164
-
-
Jemec, G.B.E.1
-
4
-
-
79955767562
-
Psychosocial impact of hidradenitis suppurativa: A qualitative study
-
Esmann S, Jemec GBE. Psychosocial impact of hidradenitis suppurativa: A qualitative study. Acta Derm Venereol. 2011;91(3):328-332
-
(2011)
Acta Derm Venereol.
, vol.91
, Issue.3
, pp. 328-332
-
-
Esmann, S.1
Jemec, G.B.E.2
-
5
-
-
0030434668
-
Hidradenitis suppurativa: Characteristics and consequences
-
Jemec GBE, HeidenheimM, Nielsen NH. Hidradenitis suppurativa: Characteristics and consequences. Clin ExpDermatol. 1996;21(6):419-423
-
(1996)
Clin ExpDermatol.
, vol.21
, Issue.6
, pp. 419-423
-
-
Jemec, G.B.E.1
Heidenheim, M.2
Nielsen, N.H.3
-
7
-
-
84873736911
-
Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States
-
Cosmatos I, Matcho A,Weinstein R, MontgomeryMO, Stang P. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013;68(3):412-419
-
(2013)
J Am Acad Dermatol.
, vol.68
, Issue.3
, pp. 412-419
-
-
Cosmatos, I.1
Matcho, A.2
Weinstein, R.3
Montgomery, M.O.4
Stang, P.5
-
8
-
-
51349113269
-
Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies
-
Revuz JE, Canoui-Poitrine F,Wolkenstein P, et al. Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies. J AmAcad Dermatol. 2008;59(4):596-601
-
(2008)
J AmAcad Dermatol.
, vol.59
, Issue.4
, pp. 596-601
-
-
Revuz, J.E.1
Canoui-Poitrine, F.2
Wolkenstein, P.3
-
9
-
-
84914161660
-
The prevalence of inverse recurrent suppuration: A population-based study of possible hidradenitis suppurativa
-
Vinding GR,Miller IM, Zarchi K, et al. The prevalence of inverse recurrent suppuration: A population-based study of possible hidradenitis suppurativa. Br J Dermatol. 2014;170(4):884-889
-
(2014)
Br J Dermatol.
, vol.170
, Issue.4
, pp. 884-889
-
-
Vinding, G.R.1
Miller, I.M.2
Zarchi, K.3
-
10
-
-
0029777345
-
The prevalence of hidradenitis suppurativa and its potential precursor lesions
-
Jemec GBE, HeidenheimM, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions.J AmAcadDermatol. 1996;35(2, pt 1):191-194
-
(1996)
J AmAcadDermatol.
, vol.35
, Issue.2
, pp. 191-194
-
-
Jemec, G.B.E.1
Heidenheim, M.2
Nielsen, N.H.3
-
11
-
-
84872196995
-
DavisMD. Incidence of hidradenitis suppurativa and associated factors: A population-based study of Olmsted County, Minnesota
-
Vazquez BG, Alikhan A,Weaver AL,Wetter DA, DavisMD. Incidence of hidradenitis suppurativa and associated factors: A population-based study of Olmsted County, Minnesota. J Invest Dermatol. 2013; 133(1):97-103
-
(2013)
J Invest Dermatol.
, vol.133
, Issue.1
, pp. 97-103
-
-
Vazquez, B.G.1
Alikhan, A.2
Weaver, A.L.3
Wetter, D.A.4
-
12
-
-
84857136555
-
Increased prevalence of metabolic syndrome in patients with acne inversa
-
Sabat R, Chanwangpong A, Schneider-Burrus S, et al. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One. 2012;7 (2):e31810. doi:10.1371/journal.pone.0031810
-
(2012)
PLoS One.
, vol.7
, Issue.2
, pp. e31810
-
-
Sabat, R.1
Chanwangpong, A.2
Schneider-Burrus, S.3
-
13
-
-
84896084510
-
The prevalence of metabolic syndrome in patients with hidradenitis suppurativa
-
Gold DA, Reeder VJ, Mahan MG, et al. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. J AmAcad Dermatol. 2014;70(4):699-703
-
(2014)
J Am Acad Dermatol.
, vol.70
, Issue.4
, pp. 699-703
-
-
Gold, D.A.1
Reeder, V.J.2
Mahan, M.G.3
-
14
-
-
84887902637
-
Meta-Analysis of psoriasis, cardiovascular disease, and associated risk factors
-
Miller IM, Ellervik C, Yazdanyar S, Jemec GB. Meta-Analysis of psoriasis, cardiovascular disease, and associated risk factors. J AmAcad Dermatol. 2013;69(6):1014-1024
-
(2013)
J Am Acad Dermatol.
, vol.69
, Issue.6
, pp. 1014-1024
-
-
Miller, I.M.1
Ellervik, C.2
Yazdanyar, S.3
Jemec, G.B.4
-
15
-
-
84889062964
-
Quantifying cardiovascular disease risk factors in patients with psoriasis: Ameta-Analysis
-
Miller IM, Skaaby T, Ellervik C, Jemec GB. Quantifying cardiovascular disease risk factors in patients with psoriasis: Ameta-Analysis. Br J Dermatol. 2013;169(6):1180-1187
-
(2013)
Br J Dermatol.
, vol.169
, Issue.6
, pp. 1180-1187
-
-
Miller, I.M.1
Skaaby, T.2
Ellervik, C.3
Jemec, G.B.4
-
16
-
-
84887926862
-
Maturation of an idea: A historical perspective on the association of psoriasis with themetabolic syndrome and cardiovascular disease [letter]
-
Miller IM, Jemec GBE.Maturation of an idea: A historical perspective on the association of psoriasis with themetabolic syndrome and cardiovascular disease [letter]. Arch Dermatol. 2012;148(1):112
-
(2012)
Arch Dermatol.
, vol.148
, Issue.1
, pp. 112
-
-
Miller, I.M.1
Jemec, G.B.E.2
-
18
-
-
1842842014
-
Definition of metabolic syndrome: Report of the National Heart Lung and Blood Institute/ American Heart Association conference on scientific issues related to definition
-
National Heart Lung Blood Institute.American Heart Association.
-
Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; National Heart, Lung, and Blood Institute; American Heart Association. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24(2):e13-e18
-
(2004)
Arterioscler Thromb Vasc Biol.
, vol.24
, Issue.2
, pp. e13-e18
-
-
Grundy, S.M.1
Brewer, H.B.2
Cleeman, J.I.3
Smith, S.C.4
Lenfant, C.5
-
19
-
-
84883801286
-
Study design, participation and characteristics of the Danish General Suburban Population Study
-
Bergholdt HK, Bathum L, Kvetny J, et al. Study design, participation and characteristics of the Danish General Suburban Population Study. Dan Med J. 2013;60(9):A4693
-
(2013)
Dan Med J.
, vol.60
, Issue.9
, pp. A4693
-
-
Bergholdt, H.K.1
Bathum, L.2
Kvetny, J.3
-
20
-
-
0035897696
-
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497
-
(2001)
JAMA.
, vol.285
, Issue.19
, pp. 2486-2497
-
-
-
21
-
-
70350245011
-
-
International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association;World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute American Heart Association;World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
-
Alberti KG, Eckel RH, Grundy SM, et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association;World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association;World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-1645
-
(2009)
Circulation.
, vol.120
, Issue.16
, pp. 1640-1645
-
-
Alberti, K.G.1
Eckel, R.H.2
Grundy, S.M.3
-
22
-
-
67650094848
-
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
-
International Expert Committee.
-
International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327-1334
-
(2009)
Diabetes Care.
, vol.32
, Issue.7
, pp. 1327-1334
-
-
-
23
-
-
84918585010
-
-
Institute for Rational Pharmacotherapy in Denmark. Guidelines on diabetes. Månedsbladet rationel farmakoterapi. 2006;8., Accessed May 21, 2014
-
Institute for Rational Pharmacotherapy in Denmark. Guidelines on diabetes. Månedsbladet rationel farmakoterapi. 2006;8.www.irf.dk. Accessed May 21, 2014
-
-
-
-
24
-
-
0038460302
-
-
National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report
-
Chobanian AV, Bakris GL, Black HR, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289(19):2560-2572
-
(2003)
JAMA.
, vol.289
, Issue.19
, pp. 2560-2572
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
-
25
-
-
0041633576
-
Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa
-
Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003;149(1):211-213
-
(2003)
Br J Dermatol.
, vol.149
, Issue.1
, pp. 211-213
-
-
Sartorius, K.1
Lapins, J.2
Emtestam, L.3
Jemec, G.B.4
-
26
-
-
84878546337
-
Identification of three hidradenitis suppurativa phenotypes: Latent class analysis of a cross-sectional study
-
Canoui-Poitrine F, Le Thuaut A, Revuz JE, et al. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. J Invest Dermatol. 2013;133(6):1506-1511
-
(2013)
J Invest Dermatol.
, vol.133
, Issue.6
, pp. 1506-1511
-
-
Canoui-Poitrine, F.1
Le Thuaut, A.2
Revuz, J.E.3
-
27
-
-
80052970269
-
Intensive glucose control and cardiovascular outcomes in type 2 diabetes
-
Macisaac RJ, Jerums G. Intensive glucose control and cardiovascular outcomes in type 2 diabetes. Heart Lung Circ. 2011;20(10):647-654
-
(2011)
Heart Lung Circ.
, vol.20
, Issue.10
, pp. 647-654
-
-
Macisaac, R.J.1
Jerums, G.2
-
28
-
-
84881168250
-
Metformin for the treatment of hidradenitis suppurativa: A little help along the way
-
Verdolini R, Clayton N, Smith A, Alwash N, Mannello B. Metformin for the treatment of hidradenitis suppurativa: A little help along the way. J Eur Acad Dermatol Venereol. 2013;27(9):1101-1108
-
(2013)
J Eur Acad Dermatol Venereol.
, vol.27
, Issue.9
, pp. 1101-1108
-
-
Verdolini, R.1
Clayton, N.2
Smith, A.3
Alwash, N.4
Mannello, B.5
-
29
-
-
0035799806
-
Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
-
Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-1350
-
(2001)
N Engl J Med.
, vol.344
, Issue.18
, pp. 1343-1350
-
-
Tuomilehto, J.1
Lindström, J.2
Eriksson, J.G.3
-
30
-
-
56749106312
-
JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
Ridker PM, Danielson E, Fonseca FA, et al.; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21): 2195-2207
-
(2008)
N Engl J Med.
, vol.359
, Issue.21
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
-
31
-
-
67650082354
-
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-Analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
-
Law MR, Morris JK,Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-Analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. doi:10.1136/bmj.b1665
-
(2009)
BMJ.
, vol.338
, pp. b1665
-
-
Law, M.R.1
Morris, J.K.2
Wald, N.J.3
-
32
-
-
57149133676
-
Fasting and nonfasting lipid levels: Influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction
-
Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: Influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 2008;118(20):2047-2056.
-
(2008)
Circulation.
, vol.118
, Issue.20
, pp. 2047-2056
-
-
Langsted, A.1
Freiberg, J.J.2
Nordestgaard, B.G.3
|